🇺🇸 Refresh Relieva PF in United States

447 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Product Container Issue — 79 reports (17.67%)
  2. Cataract — 67 reports (14.99%)
  3. Eye Irritation — 61 reports (13.65%)
  4. Eye Pain — 57 reports (12.75%)
  5. Dry Eye — 38 reports (8.5%)
  6. Drug Ineffective — 36 reports (8.05%)
  7. Ocular Hyperaemia — 31 reports (6.94%)
  8. Vision Blurred — 30 reports (6.71%)
  9. Visual Impairment — 25 reports (5.59%)
  10. Arthritis — 23 reports (5.15%)

Source database →

Other Ophthalmology approved in United States

Frequently asked questions

Is Refresh Relieva PF approved in United States?

Refresh Relieva PF does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Refresh Relieva PF in United States?

University of California, Berkeley is the originator. The local marketing authorisation holder may differ — check the official source linked above.